Pear Therapeutics Announces First Participant Enrolled in Virtual Real-World Study of Adults with Chronic Insomnia
Pear Therapeutics, Inc. recently announced the first participant enrolled in an open-label, decentralized clinical trial…
Arboretum_JDJuly 13, 2020